Prevascularized Microtemplated Fibrin Scaffolds for Cardiac Tissue Engineering Applications
Authors:
- 1 April 2013
- journal article
- research article
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 19 (7-8) , 967-977
Abstract
Myocardial infarction (MI) causes significant cell loss and damage to myocardium. Cell-based therapies for treatment of MI aim to remuscularize the resultant scar tissue, but the majority of transplanted cells do not survive or integrate with the host tissue. Scaffolds can improve cell retention following construct implantation, but often do little to enhance host-graft integration and/or show limited biodegradation. Fibrin is an ideal biomaterial for cardiac tissue engineering as it is a natural, biodegradable polymer that can induce neovascularization, promote cell attachment, and has tunable mechanical properties. Here we describe a novel, high-density microtemplated fibrin scaffold seeded with a tri-cell mixture of cardiomyocytes, endothelial cells (ECs), and fibroblasts to mimic native cardiac tissue in structure and cellular composition to improve cell retention and promote integration with the host tissue. Scaffolds were designed with uniform architecture of parallel 60 μm microchannels surrounded by an interconnected microporous network of 27-μm-diameter pores and mechanical stiffness comparable to native cardiac tissues (70–90kPa). Scaffold degradation was controlled with the addition of Factor XIII (FXIII) and/or protease inhibitor (aprotinin). Unmodified scaffolds had a fast degradation profile both in vitro (19.9%±3.9% stiffness retention after 10 days) and in vivo. Scaffolds treated with FXIII showed an intermediate degradation profile in vitro (45.8%±5.9%), while scaffolds treated with aprotinin or both FXIII and aprotinin showed significantly slowed degradation in vitro (60.9%±5.2% and 76.4%±7.6%, respectively, pin vitro, promoting EC-lined lumen structure formation in construct channels and colocalization of viable ECs and cardiomyocytes. In addition, constructs promoted extracellular matrix deposition by seeded cells, as shown by collagen staining within construct channels and by significant increases in construct stiffness over 10 days in vitro (209%±32%, p<0.05). The data suggest our fibrin scaffolds are ideally designed to promote graft cell survival and organization, thus improving chances of promoting construct integration with the host tissue upon implantation.Keywords
This publication has 38 references indexed in Scilit:
- Factor XIII, clot structure, thrombosisThrombosis Research, 2012
- What Does It Take to Make the Perfect Clot?Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Engineering vascularized skeletal muscle tissueNature Biotechnology, 2005
- Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardiumBiomaterials, 2005
- Fibrin Glue Alone and Skeletal Myoblasts in a Fibrin Scaffold Preserve Cardiac Function after Myocardial InfarctionTissue Engineering, 2004
- Aprotinin and preservation of myocardial function after ischemia-reperfusion injuryThe Annals of Thoracic Surgery, 2003
- Neovascularization of synthetic membranes directed by membrane microarchitectureJournal of Biomedical Materials Research, 1995
- Effects of fibrin on the angiogenesis in vitro of bovine endothelial cells in collagen gelIn Vitro Cellular & Developmental Biology - Animal, 1995
- Neovascularization of immunoisolation membranes: the effect of membrane architecture and encapsulated tissue.1992
- Subunit b of factor XIII is present in bovine plateletsThrombosis Research, 1988